{"id":24231,"date":"2024-12-22T22:20:28","date_gmt":"2024-12-22T21:20:28","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=24231"},"modified":"2026-04-19T11:35:20","modified_gmt":"2026-04-19T09:35:20","slug":"triple-g-retatrutide-pen-4-mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/en\/shop-product\/triple-g-retatrutide-pen-4-mg\/","title":{"rendered":"Triple G pen 4mg GLP3"},"content":{"rendered":"<div data-elementor-type=\"product-post\" data-elementor-id=\"24231\" class=\"elementor elementor-24231\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5c4c2fb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5c4c2fb\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-fd6493e\" data-id=\"fd6493e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c7da367 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"c7da367\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h2 data-start=\"281\" data-end=\"362\"><strong data-start=\"284\" data-end=\"362\">Triple G Retatrutide - what is this modern peptide<\/strong><\/h2><p data-start=\"405\" data-end=\"888\">Triple G Retatrutide also known as GLP 3, is an innovative next-generation peptide designed as an advanced agonist of triple incretin receptors (GLP-1, GIP and GCGR). The substance represents the next stage in the development of metabolic and weight-loss therapies, combining the properties of three key hormones responsible for regulating appetite, glucose metabolism and energy burning. This makes it stand out significantly from earlier formulations such as semaglutide or tirzepatyd.<\/p><hr data-start=\"890\" data-end=\"893\" \/><h2 data-start=\"895\" data-end=\"935\"><strong data-start=\"899\" data-end=\"935\">Triple G Retatrutide - mechanism of action<\/strong><\/h2><p data-start=\"936\" data-end=\"1032\">The mechanism of action of Triple G Retatrutide is based on simultaneous activation of three receptors:<\/p><ul><li><strong data-start=\"1035\" data-end=\"1070\">GLP-1 (glucagon-like peptide-1)<\/strong> - reduces appetite, slows gastric emptying and promotes insulin secretion.<\/li><li><strong data-start=\"1157\" data-end=\"1207\">GIP (glucose-dependent insulinotropic peptide)<\/strong> - Improves cellular sensitivity to insulin and contributes to better energy utilization.<\/li><li><strong data-start=\"1306\" data-end=\"1334\">GCGR (glucagon receptor)<\/strong> - Increases energy consumption and supports fat burning processes.<\/li><\/ul><p data-start=\"1403\" data-end=\"1561\">The combination of these three mechanisms produces a synergistic effect - more effective weight control, glucose stabilization and improved metabolic parameters.<\/p><hr data-start=\"1563\" data-end=\"1566\" \/><h2 data-start=\"1568\" data-end=\"1607\"><strong data-start=\"1572\" data-end=\"1607\">Triple G Retatrutide - effects according to studies (scientific information)<\/strong><\/h2><p data-start=\"1608\" data-end=\"1707\">The use of Retatrutide commonly known as GLP 3 in clinical trials has been associated with a number of effects:<\/p><ul><li data-start=\"1710\" data-end=\"1783\">Significant weight reduction (average 20-25% in <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\">research<\/a> of 2023),<\/li><li data-start=\"1786\" data-end=\"1831\">Improving blood sugar control,<\/li><li data-start=\"1834\" data-end=\"1891\">Reduction in cravings and frequency of snacking,<\/li><li data-start=\"1894\" data-end=\"1981\">Improving lipid profile (lowering triglycerides and LDL cholesterol),<\/li><li data-start=\"1984\" data-end=\"2049\">Increase energy expenditure and speed up metabolism.<\/li><\/ul><p data-start=\"2051\" data-end=\"2262\">Thanks to its triple mechanism, Retatrutide shows a much more potent effect than classic GLP-1 analogs, making it one of the most promising peptides for the treatment of obesity and metabolic syndrome.<\/p><hr data-start=\"2264\" data-end=\"2267\" \/><h2 data-start=\"2269\" data-end=\"2311\"><strong data-start=\"2273\" data-end=\"2311\">Retatrutide vs Tirzepatide (scientific data)<\/strong><\/h2><p data-start=\"2312\" data-end=\"2507\">Thiothiazepatide, which is a dual agonist (GLP-1\/GIP), has already revolutionized the treatment of obesity. However, Retatrutide adds a third element - receptor activation <strong data-start=\"2467\" data-end=\"2491\">glucagon (GCGR)<\/strong>.<br data-start=\"2492\" data-end=\"2495\" \/>It causes:<\/p><ul><li data-start=\"2510\" data-end=\"2556\">Stronger stimulation of fat metabolism,<\/li><li data-start=\"2559\" data-end=\"2597\">greater increase in energy expenditure,<\/li><li data-start=\"2600\" data-end=\"2649\">faster and more lasting weight reduction results.<\/li><\/ul><p data-start=\"2651\" data-end=\"2795\">In short, Retatrutide is the next step after Thiothrombotide, offering more complete metabolic action and potentially better clinical outcomes.<\/p><p data-start=\"2651\" data-end=\"2795\">Also check the reagent <a href=\"https:\/\/tirzepatyd.eu\/en\/shop-product\/glp-1gip-glucagon-retatrutide-8-mg-4x2mg-in-measuring-device\/\" target=\"_blank\" rel=\"noopener\">Retatrutide 8 mg in the device<\/a><\/p><hr data-start=\"2797\" data-end=\"2800\" \/><h2 data-start=\"2802\" data-end=\"2858\"><strong data-start=\"2806\" data-end=\"2858\">Triple G Retatrutide - dosage regimens (by study)<\/strong><\/h2><p data-start=\"2859\" data-end=\"3246\">In clinical trials (including. <em data-start=\"2890\" data-end=\"2930\">SURMOUNT-3 and SURPASS Obesity Extension<\/em>) scheme was used <strong data-start=\"2950\" data-end=\"2990\">Weekly subcutaneous injections<\/strong>, starting with low doses (e.g. 2 mg) and gradually increasing to 8 mg or 12 mg, depending on the body's tolerance and the results of therapy.<br data-start=\"3128\" data-end=\"3131\" \/>Individual dosage should always be determined on the basis of clinical data and the recommendations of the attending physician.<\/p><hr data-start=\"3768\" data-end=\"3771\" \/><h2><strong data-start=\"3777\" data-end=\"3820\">GLP 3 - summary<\/strong><\/h2><p data-start=\"3821\" data-end=\"4229\">Retatrutide GLP 3 is currently in clinical trials (including a Phase III study by Eli Lilly) and has not yet been approved for broad marketing. However, the results of scientific analyses to date suggest that it may represent the most effective form of next-generation metabolic therapy.<br data-start=\"4107\" data-end=\"4110\" \/>The peptide could revolutionize approaches to treating obesity and sugar disorders in the coming years.<\/p><p data-start=\"3821\" data-end=\"4229\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-25348 size-medium\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-300x192.png\" alt=\"Triple G Retatrutide peptide GLP 3 4 mg in a measuring device (pen) for research use\" width=\"300\" height=\"192\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-300x192.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-400x256.png 400w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-800x513.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-64x41.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-1024x656.png 1024w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-768x492.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259-1536x985.png 1536w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/01\/reta-4-mg-e1736292909259.png 1663w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><hr data-start=\"3768\" data-end=\"3771\" \/><p><strong>Source:<\/strong><br \/><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2301972\">Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial<\/a><\/p><div class=\"elementor-element elementor-element-6cde8ce elementor-widget elementor-widget-text-editor\" data-id=\"6cde8ce\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\"><div class=\"elementor-widget-container\"><p><strong>Product intended for scientific research and laboratory analysis. All articles and information on this site are for informational and educational purposes only.<\/strong><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Retatrutide Pen (GLP-3) is the focus of contemporary metabolic peptide research focusing on the regulation of appetite, energy management and body mass balance. Certified product, with Certificate of Analysis (CoA) attached.<\/p>","protected":false},"featured_media":25348,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[122,109,15],"product_tag":[],"class_list":{"0":"post-24231","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-penie","7":"product_cat-triple-g","8":"product_cat-laboratory-research","10":"first","11":"instock","12":"sale","13":"shipping-taxable","14":"purchasable","15":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/24231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/comments?post=24231"}],"version-history":[{"count":24,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/24231\/revisions"}],"predecessor-version":[{"id":35481,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/24231\/revisions\/35481"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/media\/25348"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/media?parent=24231"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_brand?post=24231"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_cat?post=24231"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_tag?post=24231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}